Reported covered position: Government Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
COVID–19 Nursing Home Protection Act of 2021
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
american rescue plan, S333(nursing home protection act) S784
Medicare-X Choice Act of 2021
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
medicare part D costs, medicare sequester, S386 Medicare - X Choice act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS via AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2021 · first_quarter · 1T
american rescue plan, S333(nursing home protection act) S784
medicare part D costs, medicare sequester, S386 Medicare - X Choice act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Jobs for Economic Recovery Act of 2021
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
american rescue plan, S333(nursing home protection act) S784
Phair Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Phair Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Phair Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Phair Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Understanding Appropriate Alzheimer’s Care Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Understanding Appropriate Alzheimer’s Care Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Understanding Appropriate Alzheimer’s Care Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Understanding Appropriate Alzheimer’s Care Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Quality Care for Nursing Home Residents Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Quality Care for Nursing Home Residents Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Quality Care for Nursing Home Residents Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Quality Care for Nursing Home Residents Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Transparent Drug Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Transparent Drug Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Transparent Drug Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Transparent Drug Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Phair Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Phair Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Phair Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances
Payment Commission Data Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Understanding Appropriate Alzheimer’s Care Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Understanding Appropriate Alzheimer’s Care Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances
Understanding Appropriate Alzheimer’s Care Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances
Safe Step Act
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
H.R. 2279, Step Therapy appeals, Drug Pricing, Provider Status
Safe Step Act
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
H.R. 2279, Step Therapy appeals, Drug Pricing, Provider Status
Safe Step Act
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
H.R. 2279, Step Therapy appeals, Drug Pricing, Provider Status
Quality Care for Nursing Home Residents Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Transparent Drug Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Transparent Drug Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Transparent Drug Pricing Act of 2019
Client: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS · Firm: AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
2020 · fourth_quarter · Q4
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS via AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2020 · third_quarter · Q3
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS via AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2020 · second_quarter · Q2
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS via AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2020 · first_quarter · Q1
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS via AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2019 · fourth_quarter · Q4
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances S2943 - To amend titles XVIII and XIX of the Social Security Act to revise minimum nurse staffing requirements for skilled nursing facilities under the Medicare program and for nursing facilities under the Medicaid program, and for other purposes.
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS via AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2019 · third_quarter · Q3
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS via AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2019 · second_quarter · Q2
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS via AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2019 · second_quarter · RA
H.R. 2279, Step Therapy appeals, Drug Pricing, Provider Status
H.R. 2279, Step Therapy appeals, Drug Pricing, Provider Status
H.R. 2279, Step Therapy appeals, Drug Pricing, Provider Status
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. medication reviews under Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT) Act. specialty drugs in nursing homes
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
HR1781 - Payment Commission Data Act of 2019, to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR2279, to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR1955 - Understanding Appropriate Alzheimer's Care Act of 2019, to require the Administrator of the Centers for Medicare & Medicaid Services to conduct a study on antipsychotic prescribing practices in non-nursing home settings under the Medicare program, and for other purposes. Issues related to nurse agency in nursing homes when prescribing controlled substances
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
S977 - Transparent Drug Pricing Act of 2019, to address the high cost of prescription drugs. HR1034 - Phair Pricing Act of 2019, to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes. Provider status, to recognize pharmacists as healthcare providers in the Social Security Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE